Over-the-Counter Diagnostic Products World Markets

Content

• 1 Overview
  • 1.1 Statement Of Report
  • 1.2 About This Report
  • 1.3 Scope Of The Report
  • 1.4 Objectives
  • 1.5 Methodology
  • 1.6 Executive Summary
• 2 Sector Overview
  • 2.1 Global Diagnostic Products Industry
  • 2.2 Global Otc Diagnostic Products Industry
    • 2.2.1 General Global Market
    • 2.2.2 German Otc And Home Self-Testing Diagnostic Markets
    • 2.2.3 U.K. Otc And Home Self-Test Diagnostic Markets
      • 2.2.3.1 U.K. Market Statistics
      • 2.2.3.2 U.K. Competitive Analysis
      • 2.2.3.3 U.K. Market Access
    • 2.2.4 French Otc Diagnostic Market
    • 2.2.5 Italian Otc Diagnostic Market
    • 2.2.6 Spanish Otc Diagnostic Market
    • 2.2.7 Japanese Otc Diagnostic Market
    • 2.2.8 Chinese Otc Diagnostic Market
  • 2.3 Description Of The U.S. Otc Diagnostics Industry Segment
    • 2.3.1 Market Overview
    • 2.3.2 Diagnostic Test Categories
  • 2.4 Market Drivers In The Otc Diagnostics Sector
    • 2.4.1 Overview
    • 2.4.2 Market Segments
  • 2.5 Key Players In The Otc Diagnostics Segment
  • 2.6 Sector Analysis
• 3 Market Analysis: Size, Growth, Share And Competitors
  • 3.1 Glucose Monitoring
    • 3.1.1 Glucose Control In Diabetic Patients
    • 3.1.2 Tight Glucose Control In Treating Diabetes
    • 3.1.3 Glucose-Monitoring Devices
    • 3.1.4 Key Issues For Glucose Monitoring
    • 3.1.5 Glucose Device Description
    • 3.1.6 Precision In Glucose Meters
    • 3.1.7 Limitations Of Existing Glucose Monitoring Products
    • 3.1.8 Over-The-Counter (Otc) Self-Testing Glucose Market
    • 3.1.9 Worldwide Glucose Testing Market
      • 3.1.9.1 U.S. Market
      • 3.1.9.2 European Market
      • 3.1.9.3 Asian Market
      • 3.1.9.3.1 Japanese Market
      • 3.1.9.3.2 Chinese Market
      • 3.1.9.3.3 Indian Market
      • 3.1.9.4 Row Markets
    • 3.1.10 Reagents And Equipment
      • 3.1.10.1 Blood Glucose Monitoring
      • 3.1.10.2 Lancets
      • 3.1.10.3 Blood Glucose Monitor And Insulin Doser
      • 3.1.10.4 Blood Glucose Reagent Test Strips
      • 3.1.10.5 Control Solutions And Calibrators
      • 3.1.10.6 Sharps Devices
      • 3.1.10.7 Needle Destruction Devices
    • 3.1.11 Glucose Meters
    • 3.1.12 Voice-Operated Glucose Meters
  • 3.2 Pregnancy And Fertility Testing
    • 3.2.1 Major Players
      • 3.2.1.1 U.S. Market
      • 3.2.1.2 European Market
    • 3.2.2 Diagnostic Kit Information
  • 3.3 Hepatitis Testing
  • 3.4 Drugs Of Abuse Screening Testing
  • 3.5 Infectious Disease Testing
    • 3.5.1 Hiv
    • 3.5.2 Tuberculosis Testing
    • 3.5.3 Infectious Disease Testing In Non-Medical Settings
    • 3.5.4 West Nile Virus
    • 3.5.5 Urinary Tract Infections
  • 3.6 Cholesterol Testing
  • 3.7 Coagulation Testing
  • 3.8 Urine Dipstick Testing
  • 3.9 Fertility Testing
    • 3.9.1 Players
    • 3.9.2 Diagnostic Test Kits
  • 3.10 At-Home Dna Analysis
  • 3.11 Biowarfare Detection
  • 3.12 Home Patient Monitoring Devices
  • 3.13 Home Patient Alert Systems
  • 3.14 Home Genetic Testing Kits
  • 3.15 Home Paternity Testing
  • 3.16 Health Hazards Detection
    • 3.16.1 Lead
    • 3.16.2 Radon
    • 3.16.3 Asbestos
    • 3.16.4 Pesticides
    • 3.16.5 Mold
    • 3.16.6 Carbon Monoxide
    • 3.16.7 Water Quality
    • 3.16.8 Bacteria In Water
  • 3.17 Thyroid Disease
  • 3.18 Carpal Tunnel
  • 3.19 Allergies
  • 3.20 Nutrition And Wellness
    • 3.20.1 Testosterone And Male Hormones
    • 3.20.2 Female Hormones
    • 3.20.3 Antioxidants
    • 3.20.4 Sleep Apnea
    • 3.20.5 Mineral Check
    • 3.20.6 Stress Check
  • 3.21 Colorectal Cancer (Occult Blood) Testing
  • 3.22 Alzheimer S Disease Home Screening Test
  • 3.23 Tobacco Testing
• 4. Business Trends In The Industry
  • 4.1 Wholesale Distribution Overview
  • 4.2 Factors Affecting Otc Medical Product Distribution
  • 4.3 Government Regulation Of Medical Devices
    • 4.3.1 U.S. Regulations
    • 4.3.2 U.K. Regulations
  • 4.4 Clinical Laboratory Improvement Act (Clia)
  • 4.5 Legal, M&a And Corporate Partnerships
• 5. Patient Management Trends
  • 5.1 Trends In Otc Testing And Reimbursement
    • 5.1.1 American Otc Testing And Home Self-Testing Reimbursement
    • 5.1.2 European Reimbursement
  • 5.2 Drivers Of Otc And Home Self-Testing
  • 5.3 Cost Elements Of Otc Testing
  • 5.4 Important Elements Of Otc Testing
  • 5.5 Growth Of Home Care Testing
  • 5.6 Non-Traditional Methods For Sample Collection
• 6. Technology Trends
  • 6.1 Sensor Systems For Diagnostic Applications
  • 6.2 Glucose Measurements
  • 6.3 Cholesterol Testing
  • 6.4 Immunoassay Technology
  • 6.5 Biosensor Technology
  • 6.6 Fructosamine Test
  • 6.7 Home Telemedicine Devices
• 7. Otc Testing: Critical Issues
  • 7.1 Moderators Of Growth For Otc Testing
  • 7.2 Attitudes Of Critical Care Nurses And Physicians
  • 7.3 Personnel Impact For Otc Testing
  • 7.4 Data Management Issues
  • 7.5 Poc Decentralization Issues
  • 7.6 Poc Testing And Clinical Outcomes
  • 7.7 Focused Testing
  • 7.8 Satellite Facilities
  • 7.9 Poc Testing Comparison And Cost Analysis
• 8. Competitive Assessments Of The High-Growth Markets
  • 8.1 Glucose Monitoring
    • 8.1.1 Overview Of Market Segment
    • 8.1.2 Competitive Strategies
    • 8.1.3 Analyses Of The Current Market Conditions, Competition And Product Mix
    • 8.1.4 Adjacent Markets
    • 8.1.5 Market Drivers And Restraints
    • 8.1.6 Market And Product Trends
  • 8.2 Coagulation Testing
    • 8.2.1 Overview Of Market Segment
    • 8.2.2 Competitive Strategies
    • 8.2.3 Analyses Of Current Market Conditions
    • 8.2.4 Product Mix In Coagulation Testing
    • 8.2.5 Adjacent Markets
    • 8.2.6 Market Drivers And Restraints
    • 8.2.7 Market And Product Trends
  • 8.3 Cholesterol Testing
    • 8.3.1 Overview Of Market Segment
    • 8.3.2 Competitive Strategies
    • 8.3.3 Adjacent Markets
  • 8.4 Infectious Disease Testing
    • 8.4.1 Overview Of Market Segment
    • 8.4.2 Competitive Strategies
  • 8.5 Drugs Of Abuse
    • 8.5.1 Overview Of Market Segment
    • 8.5.2 Analyses Of The Current Market Conditions, Competition And Product Mix
    • 8.5.3 Adjacent Markets
  • 8.6 Home Pregnancy Testing
    • 8.6.1 Overview Of Market Segment
    • 8.6.2 Competitive Strategies
    • 8.6.3 Analysis Of Current Market Conditions
    • 8.6.4 Product Mix
    • 8.6.5 Adjacent Markets
    • 8.6.6 Market Drivers And Restraints
    • 8.6.7 Market And Product Trends
• 9. Current Issues For Otc And Home Diagnostic Testing
  • 9.1 New Markets For Otc And Home Diagnostic Testing
  • 9.2 Utility Of Otc And Home Self-Testing
  • 9.3 Corporate Screening
  • 9.4 Generational Drivers Of Home Testing
  • 9.5 Move Away From Central Laboratories
  • 9.6 Healthcare Cost Controls
  • 9.7 Mergers Of Diagnostic Companies
  • 9.8 Home Healthcare Trends
  • 9.9 Home Healthcare Providers Versus Mass Market Retailers
  • 9.10 Demographic Merchandising
  • 9.11 Marketing Strategies
  • 9.12 Third-Party Pharmacy Networks
  • 9.13 Which Customer Segments Purchase Home Healthcare Which Products Fit Their Needs
  • 9.14 Future Of Patient Self-Testing
• 10. Corporate Profiles
  • 10.1 Abbott Diagnostics
  • 10.2 Amerisourcebergen
  • 10.3 Bayer Diagnostics
  • 10.4 Becton Dickinson
  • 10.5 Bindley Western Industries, Inc
  • 10.6 Biosite, Inc
  • 10.7 Cardinal Health, Inc
  • 10.8 Cholestech
  • 10.9 Hemocue
  • 10.10 Home Access Health Corp
  • 10.11 Inverness Medical Innovations, Inc
  • 10.12 Johnson & Johnson
  • 10.13 Lifescan
  • 10.14 Princeton Biomeditech
  • 10.15 Quidel Corp
  • 10.16 Roche Diagnostics
  • 10.17 Saliva Diagnostics
• 11. Corporate Directory
  • Appendix 1: Over-The-Counter In Vitro Diagnostic Devices
  • Appendix 2: Otc Waived Tests For Drugs Of Abuse
  • Appendix 3: Fda Approved And Unapproved Tests For Hiv Home Testing
  • Appendix 4: Home Medical Equipment Reimbursement Contacts For Medicare
  • Appendix 5: Frequently-Asked Questions About Drug Screening Kits
• Index Of Figures
  • Figure 2.1: European Otc Diagnostic Products Market By Country
  • Figure 3.1: Single-Day Continuous Blood Glucose Data
  • Figure 3.2: Share Of The U.S. Self-Testing Diagnostic Market, 2008
  • Figure 3.3: The Glucose Market U.S. Sales, 2000-2012
• Index Of Tables
  • Table 2.1: Market Share Of Top Three In Vitro Diagnostic Companies
  • Table 2.2: Worldwide Clinical Laboratory Market Size, 2003-2012
  • Table 2.3: U.S. Clinical Laboratory Testing Market, 2003-2012
  • Table 2.4: Worldwide Near-Patient Diagnostic Testing, 2003-2013
  • Table 2.5: Worldwide Otc Diagnostic Products Market, 2003-2013
  • Table 2.6: Worldwide Otc Diagnostic Products Market By Region, 2008
  • Table 2.7: Major European Otc Diagnostics Markets, 2008
  • Table 2.8: German Otc Diagnostic Products Market Sales, 2003-2013
  • Table 2.9: U.K. Otc Diagnostic Products Market Sales, 2003-2013
  • Table 2.10: Major U.K. Ivd Manufacturers
  • Table 2.11: U.S. Ivd Manufacturers Doing Business In The U.K
  • Table 2.12: Other European Companies That Manufacture Ivd Products In The U.K
  • Table 2.13: French Otc Diagnostic Products Market Sales, 2003-2013
  • Table 2.14: Italian Otc Diagnostic Products Market Sales, 2003-2013
  • Table 2.15: Spanish Otc Diagnostic Products Market Sales, 2003-2013
  • Table 2.16: Japanese Otc Diagnostic Products Market Sales, 2003-2013
  • Table 2.17: Chinese Otc Diagnostic Products Market Sales, 2003-2013
  • Table 2.18: U.S. Otc Diagnostic Products Market Sales 2003-2013
  • Table 2.19: U.S. Clinical Diagnostic Home Test Market Segments
  • Table 2.20: Top Drugstore Retailers In The U.S
  • Table 2.21: Top Drugstore Wholesalers In The U.S
  • Table 3.1: Market For Otc Glucose Self-Testing In The U.S., 2004-2012
  • Table 3.2: Glucose Market For Otc Testing Worldwide, 2003-2013
  • Table 3.3: Top Ten Countries In Number Of Persons With Diabetes (Aged 20 To 79 Years), In 2007 And 2025
  • Table 3.4: Share Of The U.S. Self-Testing Diagnostic Market, 2008
  • Table 3.5: Otc Blood Glucose Instrument Reagents By Manufacturer Retail
  • Table 3.6: World Market Share Of Poc Glucose Monitoring Marketers
  • Table 3.7: Key Features Considered For Glucose Meter Devices
  • Table 3.8: Demographic Characteristics Home-Testing Kit Buyers
  • Table 3.9: Top Brand Preferences For Home Glucose Testing Kits
  • Table 3.10: Instances When Patients Prefer Professional S Glucose Testing
  • Table 3.11: Advantages Of A Home-Testing Kit
  • Table 3.12: Disadvantages Of Using A Home-Testing Kit
  • Table 3.13: Popular Shopping Destinations For Buying Or Seeking Information On Home Testing Kits
  • Table 3.14: Worldwide Glucose Self-Testing Market Sales (Meters, Strips, Lancets), 2000-2013
  • Table 3.15: The Glucose Market For Self-Testing And Poc Devices In The U.S., 2003-2013
  • Table 3.16: U.S. Blood Glucose Reagent Strip Market, 2004-2013
  • Table 3.17: Otc Glucose Meter U.S. Market Share For Blood Glucose Measurements
  • Table 3.18: U.S. Diabetes Glucose Monitoring Market Repeat Retail Replacement Sales Percentages
  • Table 3.19: Top Four Players In The U.S. Blood Glucose Strips Market Ranked By Percentage Sales, 2008
  • Table 3.20: Leading Blood Glucose Meters And Strips Brands In The U.S., 2008
  • Table 3.21: European Glucose Self-Testing Market (Meters, Strips, Lancets), 2004-2013
  • Table 3.22: European Glucose Self-Testing Market By Country Market
  • Table 3.23: Asian Glucose Self-Testing Market (Meters, Strips, Lancets), 2004-2012
  • Table 3.24: Japanese Glucose Self-Testing Market (Meters, Strips, Lancets), 2002-2012
  • Table 3.25: Chinese Glucose Self-Testing Market (Meters, Strips, Lancets), 2003-2012
  • Table 3.26: Chinese Blood Glucose Reagent Strip Market, 2000-2012
  • Table 3.27: Indian Glucose Self-Testing Market (Meters, Strips, Lancets), 2000-2012
  • Table 3.28: Indian Blood Glucose Reagent Strip Market, 2000-2012
  • Table 3.29: Row Glucose Self-Testing Market (Meters, Strips, Lancets), 2003-2013
  • Table 3.30: Unit Sales Of Homecare Lancets In The U.S., 2003-2013
  • Table 3.31: Unit Sales Of Lancets In The E.U., 2003-2013
  • Table 3.32: Dollar Sales Of Lancets In The U.S., 2003-2013
  • Table 3.33: Dollar Sales Of Lancets In The E.U., 2003-2013
  • Table 3.34: Unit Sales Of Homecare Glucose Self-Testing Lancets In The U.S., 2003-2013
  • Table 3.35: Unit Sales Of Homecare Glucose Self-Testing Lancets In The E.U., 2003-2013
  • Table 3.36: Competition In The Lancet Market Segment
  • Table 3.37: Key Features Of Reagent Test Strips
  • Table 3.38: Customer Priorities Glucose Meter Self-Testing Market, 2001, 2006 And 2012
  • Table 3.39: Accu-Chek Blood Glucose Monitoring Systems
  • Table 3.40: Pregnancy Test Market For Otc Testing In The U.S., 2000 2012
  • Table 3.41: Pregnancy Test Market For Otc Testing In Europe, 2003 2013
  • Table 3.42: U.S. Market Share For Home Pregnancy Tests
  • Table 3.43: European Market Share For Otc Pregnancy Tests
  • Table 3.44: Home Pregnancy Tests Available In The U.S. Market
  • Table 3.45: Hepatitis C Statistics
  • Table 3.46: Hepatitis Market For Otc Testing In The U.S., 2003-2013
  • Table 3.47: U.S. Poc Drugs Of Abuse Testing Market In The U.S., 2006 2012
  • Table 3.48: Illicit Drugs That Are Important For Detection
  • Table 3.49: Analytical Detection Levels For Drugs Of Abuse
  • Table 3.50: Princeton Biomeditech S Drugs Of Abuse Tests
  • Table 3.51: Abbott Drugs Of Abuse Tests On The Architect System
  • Table 3.52: Infectious Disease Market For Otc Testing In The U.S., 2003-2013
  • Table 3.53: Hiv Testing Market For Otc Testing In The U.S., 2003-2013
  • Table 3.54: Home Testing For Urinary Tract Infections
  • Table 3.55: Cholesterol Market For Otc And Home Self-Testing In The U.S., 2003-2013
  • Table 3.56: Coagulation Market For Otc Testing In The U.S., 2003-2013
  • Table 3.57: Glucose Market For Otc Testing In The U.S., 2003-2013
  • Table 3.58: Fertility Testing Market For Otc Testing In The U.S., 2003-2013
  • Table 3.59: Fertility Testing Market For Otc Testing In Europe, 2003-2013
  • Table 3.60: Rite Aid And Other Oem Ovulation Predictors
  • Table 3.61: At-Home Dna Tests
  • Table 3.62: At-Home Dna Market For Otc Testing Worldwide, 2003 2013
  • Table 3.63: Home Genetic Testing Market In The U.S., 2003-2013
  • Table 3.64: Genovations Profiles
  • Table 3.65: Featured Tests By Dna Direct
  • Table 3.66: Fee Schedule For Personal Home-Based Paternity Studies
  • Table 4.1: Financial Comparison For Moderate And Waived Clia Labs
  • Table 5.1: U.S. Home Testing Market Size, 2003-2013
  • Table 6.1: Normal Glucose Values, Fasting State
  • Table 6.2: Leading Home Patient Monitoring Products In The U.S. Market
  • Table 7.1: Poc Testing: Cost Analysis
  • Table 7.2: Poc Testing: Cost Analysis With Labor Included
  • Table 8.1: Total World Cholesterol Testing Market, 2006-2012
  • Table A.1: Over-The-Counter In Vitro Diagnostic Devices